Abbvie shares tumble after CVS drops Humira in favor of biosimilars
CNBC's Bertha Coombs joins 'Fast Money' to talk Abbvie's stock sliding in extended trading after CVS announced it is dropping coverage of Humira.
Видео Abbvie shares tumble after CVS drops Humira in favor of biosimilars канала CNBC Television
Видео Abbvie shares tumble after CVS drops Humira in favor of biosimilars канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Opening Bell, November 4, 2022
Ed Yardeni: We're still in the early stages of a bull market
Breaking down shares of Hilton, Expedia and Match Group
Kraken's chief legal officer: SEC's suit against crypto exchange 'never should have been brought'
Lockheed Martin sees record order volume in 2022 as earnings beat estimates
Carl Icahn to CNBC: I like Caesars and I own some stock
The path for a soft landing has narrowed some, says WSJ's Nick Timiraos
Opportunistic credit investing: Strategic Value Partners' Victor Khosla on finding opportunities
Faber Report: Skydance poised to announce takeover of Paramount
Ether soars 27% in May after SEC clears path for spot ether ETFs: CNBC Crypto World
Johnson & Johnson CEO: Our aim is to become the number one oncology company
We are focused on our organic roadmap, says Box CEO
Marriott CEO: Resilience in luxury travel has been one of the real bright spots in travel recovery
Retail earnings show consumers are 'keeping the spending going', says Jan Kniffen
New cancer drug data announced: Here's what to know
Clean Start: This clean-tech startup transforms carbon emissions into vodka
Cybersecurity is going to be just as big as AI, says Hightower's Stephanie Link
Greylock partner Reid Hoffman on launch of 'Reid AI', deepfake concerns and state of AI arms race
Trade Alert: Bill Baruch buys ConocoPhillips and sells Nucor
Calls of the Day: Charles Schwab, Qualcomm and McDonald's
Some view Nvidia as a parvenu even though its a well established company overall, says Jim Cramer